推荐产品
产品名称
抗-淀粉样蛋白抗体，β 1-16，克隆DE2, culture supernatant, clone DE2, Chemicon®
生物来源
mouse
质量水平
抗体形式
culture supernatant
抗体产品类型
primary antibodies
克隆
DE2, monoclonal
种属反应性
monkey, bovine, human
制造商/商品名称
Chemicon®
技术
ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
同位素/亚型
IgG
UniProt登记号
运输
dry ice
靶向翻译后修饰
unmodified
基因信息
human ... APP(351)
应用
抗淀粉样蛋白抗体，β1-16，克隆DE2是一种针对淀粉样蛋白的抗体，用于ELISA、WB、IH(P)。
蛋白质印迹：1:10-1:300免疫组织化学：1:10-1:200在甲醛固定、石蜡包埋的组织上，需要甲酸或微波预处理来染色阿尔兹′海默病大脑老年斑。ELISA免疫沉淀
最佳工作稀释度必须由最终用户确定。
最佳工作稀释度必须由最终用户确定。
外形
培养上清液。 含有0.02%叠氮化钠的液体。
法律信息
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
WGK
WGK 1
Mélanie Sipion et al.
Scientific reports, 13(1), 19828-19828 (2023-11-15)
Photobiomodulation (PBM), the process of exposing tissue to red or near-infrared light, has become a topic of great interest as a therapy for diverse pathologies, including neurodegenerative disorders. Here, we aimed to evaluate the potential beneficial effect of PBM on
Alexander J Ehrenberg et al.
Acta neuropathologica, 141(5), 651-666 (2021-03-08)
The farnesyltransferase inhibitor, Lonafarnib, reduces tau inclusions and associated atrophy in familial tauopathy models through activation of autophagy, mediated by the inhibition of farnesylation of the Ras GTPase, Rhes. While hinting at a role of Rhes in tau aggregation, it
S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.
Kim, HJ; Chang, KA; Ha, TY; Kim, J; Ha, S; Shin, KY; Moon, C; Nacken, W; Kim, HS; Suh, YH
Testing null
Avindra Nath et al.
Neuromolecular medicine, 3(1), 29-39 (2003-04-01)
Studies of amyloid precursor protein transgenic mice suggest that immune responses to amyloid beta peptide (Abeta) may be instrumental in the removal of plaques from the brain, but the initial clinical trial of an Abeta vaccine in patients with Alzheimer
Tomàs Jordà-Siquier et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 18(11), 2099-2116 (2022-01-26)
In Alzheimer's disease (AD), the distribution of the amyloid precursor protein (APP) and its fragments other than amyloid beta, has not been fully characterized. Here, we investigate the distribution of APP and its fragments in human AD brain samples and
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门